- Home
- Life Sciences
- Pharmaceutical
- Drug Discovery and Development
- Drug Discovery and Development Analysis & Statistics in the United States, June 2013
Free Market Research Guides to Download
Drug Discovery and Development Analysis & Statistics in the United States, June 2013
You might be interested in: clinical trial, drug discovery, drug development, more »
» Purchase Premium Reports
1-7 of 7 reports
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy
- $ 3 500
- Industry report
- September 2012
- by GBI Research
Engaging Key Opinion Leaders (KOLs) - Identifying and Leveraging New KOL Groups to Drive Medical Marketing Strategy Summary GBI Research, the leading business intelligence provider, has released its ...
- Industries : Drug Discovery and Development
- Countries : United States
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity
- $ 3 500
- Industry report
- September 2012
- by GBI Research
Pathways to Efficient Drug Development - Advances in Modeling and Simulation Outcomes to Fuel Pipeline Productivity Summary GBI Research, the leading business intelligence provider, has released its ...
- Industries : Drug Discovery and Development
- Countries : United States
Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward
- $ 3 500
- Industry report
- June 2012
- by GBI Research
Workforce Reductions in Pharmaceuticals - Outsourcing, External Innovation and Collaboration Will Drive the Industry Forward Summary GBI Research, the leading business intelligence provider, has released ...
- Industries : Drug Discovery and Development
- Countries : United States
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge
- $ 3 500
- Industry report
- May 2012
- by GBI Research
Patient Perspectives - Patient Reported Outcomes Drive Drug Development, but Improving Patient Involvement Remains a Challenge Summary GBI Research, the leading business intelligence provider, has released ...
- Industries : Drug Discovery and Development
- Countries : United States
Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance
- $ 3 500
- Industry report
- September 2011
- by GBI Research
Post Marketing Clinical Research - REMS, the Latest Reformation due to Post Marketing Surveillance to Enhance Patient Compliance Summary GBI Research has released its latest report, ?Post Marketing Clinical ...
- Industries : Drug Discovery and Development
- Countries : United States, Japan, Europe, World
Lifesciences IT - 2011 Yearbook
- $ 3 500
- Industry report
- June 2011
- by GBI Research
Lifesciences IT - 2011 Yearbook Summary GBI Research's research, ?Lifesciences IT - 2011 Yearbook" provides key data, information and analysis on Lifesciences \IT that is being implemented by pharmaceutical ...
- Industries : Drug Discovery and Development
- Countries : United States, India, World
Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- $ 3 500
- Industry report
- March 2011
- by GBI Research
Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies Summary GBI Research, the leading business intelligence provider, has released its ...
- Industries : Drug Discovery and Development
- Countries : World, United States, Europe, Switzerland, Sweden, Spain, Italy, France, Germany, Denmark, Belgium, Canada
» Download Public Reports
About 1 900 reports
The United States: Brief Outlook, 2013, focus on Drug Discovery and Development
- Country report
- April 2013
- 14 pages
Evotec Ag - Company Report For Year 2013
April 2013Reportlinker.com © Copyright 2013. All rights reserved.
